Preimplantation Genetics Diagnosis (PGD) Market

Global Preimplantation Genetics Diagnosis (PGD) Market Size, Share & Industry Trends Analysis Report By Test Type (Aneuploidy, Chromosomal Abnormalities, X-linked diseases), By Regional Outlook and Forecast, 2022 - 2028

Report Id: KBV-8882 Publication Date: May-2022 Number of Pages: 143
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
1.4.2 Global Preimplantation Genetics Diagnosis (PGD) Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Preimplantation Genetics Diagnosis (PGD) Market by Test Type
3.1 Global Aneuploidy Market by Region
3.2 Global Chromosomal Abnormalities Market by Region
3.3 Global X-linked diseases Market by Region
3.4 Global Single Gene Disorders Market by Region
3.5 Global HLA Typing Market by Region
3.6 Global Gender selection Market by Region
3.7 Global Other Test Type Market by Region

Chapter 4. Global Preimplantation Genetics Diagnosis (PGD) Market by Region
4.1 North America Preimplantation Genetics Diagnosis (PGD) Market
4.1.1 North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.1.1.1 North America Aneuploidy Market by Country
4.1.1.2 North America Chromosomal Abnormalities Market by Country
4.1.1.3 North America X-linked diseases Market by Country
4.1.1.4 North America Single Gene Disorders Market by Country
4.1.1.5 North America HLA Typing Market by Country
4.1.1.6 North America Gender selection Market by Country
4.1.1.7 North America Other Test Type Market by Country
4.1.2 North America Preimplantation Genetics Diagnosis (PGD) Market by Country
4.1.2.1 US Preimplantation Genetics Diagnosis (PGD) Market
4.1.2.1.1 US Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.1.2.2 Canada Preimplantation Genetics Diagnosis (PGD) Market
4.1.2.2.1 Canada Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.1.2.3 Mexico Preimplantation Genetics Diagnosis (PGD) Market
4.1.2.3.1 Mexico Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.1.2.4 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market
4.1.2.4.1 Rest of North America Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market
4.2.1 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.1.1 Europe Aneuploidy Market by Country
4.2.1.2 Europe Chromosomal Abnormalities Market by Country
4.2.1.3 Europe X-linked diseases Market by Country
4.2.1.4 Europe Single Gene Disorders Market by Country
4.2.1.5 Europe HLA Typing Market by Country
4.2.1.6 Europe Gender selection Market by Country
4.2.1.7 Europe Other Test Type Market by Country
4.2.2 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country
4.2.2.1 Germany Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.1.1 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.2 UK Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.2.1 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.3 France Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.3.1 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.4 Russia Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.4.1 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.5 Spain Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.5.1 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.6 Italy Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.6.1 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2.2.7 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market
4.2.2.7.1 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market
4.3.1 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.1.1 Asia Pacific Aneuploidy Market by Country
4.3.1.2 Asia Pacific Chromosomal Abnormalities Market by Country
4.3.1.3 Asia Pacific X-linked diseases Market by Country
4.3.1.4 Asia Pacific Single Gene Disorders Market by Country
4.3.1.5 Asia Pacific HLA Typing Market by Country
4.3.1.6 Asia Pacific Gender selection Market by Country
4.3.1.7 Asia Pacific Other Test Type Market by Country
4.3.2 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Country
4.3.2.1 China Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.1.1 China Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.2 Japan Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.2.1 Japan Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.3 India Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.3.1 India Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.4 South Korea Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.4.1 South Korea Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.5 Singapore Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.5.1 Singapore Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.6 Malaysia Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.6.1 Malaysia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3.2.7 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market
4.3.2.7.1 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4 LAMEA Preimplantation Genetics Diagnosis (PGD) Market
4.4.1 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.1.1 LAMEA Aneuploidy Market by Country
4.4.1.2 LAMEA Chromosomal Abnormalities Market by Country
4.4.1.3 LAMEA X-linked diseases Market by Country
4.4.1.4 LAMEA Single Gene Disorders Market by Country
4.4.1.5 LAMEA HLA Typing Market by Country
4.4.1.6 LAMEA Gender selection Market by Country
4.4.1.7 LAMEA Other Test Type Market by Country
4.4.2 LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Country
4.4.2.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.1.1 Brazil Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.2 Argentina Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.2.1 Argentina Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.3 UAE Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.3.1 UAE Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.4 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.4.1 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.5 South Africa Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.5.1 South Africa Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.6 Nigeria Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.6.1 Nigeria Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4.2.7 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market
4.4.2.7.1 Rest of LAMEA Preimplantation Genetics Diagnosis (PGD) Market by Test Type

Chapter 5. Company Profiles
5.1 Illumina, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.2 Invitae Corporation
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expenses
5.3 Natera Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expenses
5.4 Agilent Technologies, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent Strategies and Developments:
5.4.5.1 Approvals and Trials:
5.5 PerkinElmer, Inc.
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expense
5.5.5 Recent Strategies and Developments:
5.5.5.1 Product Launches and Product Expansions:
5.6 Quest Diagnostics Incorporated
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental Analysis
5.7 Reproductive Genetic Innovations
5.7.1 Company Overview
5.8 PacGenomics
5.8.1 Company Overview
5.9 CeGaT GmbH
5.9.1 Company Overview
5.10. Laboratory Corporation of America Holdings
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo